Sign In
Buy OXM
$38.14
+0.260 (+0.686%)
At Close: Jun 23, 2026
Study hints antibody drug may cut COVID-19 hospitalizations
05:51pm, Wednesday, 16'th Sep 2020
A drug company says that partial results from a study testing an antibody drug give hints that it may help keep mild to moderately ill COVID-19 patients from needing to be hospitalized, a goal no curr
Eli Lilly Stock Looks Hot on New Antibody Drug Evidence
05:35pm, Wednesday, 16'th Sep 2020
Eli Lilly stock is climbing slightly higher Wednesday after it became the first company to release antibody drug results.
Eli Lilly and : Covid-19 Antibody Drug Shown to Reduce Hospitalizations, Eli Lilly Says | MarketScreener
11:00am, Wednesday, 16'th Sep 2020Eli Lilly reports a reduced rate of hospitalization for coronavirus patients using its antibody treatment
10:46am, Wednesday, 16'th Sep 2020
The antibody was identified from a blood sample taken from one of the first U.S. patients who recovered from Covid-19.
Covid-19 Antibody Drug Shown to Reduce Hospitalizations, Eli Lilly Says
10:45am, Wednesday, 16'th Sep 2020
An antibody-based drug derived from the blood of an early U.S. survivor of Covid-19 reduced the rate of hospitalization compared with a placebo in a new study of people recently diagnosed with the dis
Interim Data Reported for AbCellera-Discovered COVID-19 Antibody in Phase 2 Clinical Trials
12:00am, Wednesday, 16'th Sep 2020
Interim data from a Phase 2 clinical trial of LY-CoV555 shows a reduction in the rate of hospitalization in patients treated with the antibody.
Dicerna Pharmaceuticals May Be The Best Value Among RNAi Companies (NASDAQ:DRNA)
07:23pm, Tuesday, 15'th Sep 2020
Dicerna develops RNAi therapies. Several large-cap pharma companies are collaborators.
Eli Lilly says its arthritis drug helps accelerate recovery in COVID-19 patients treated with remdesivir
02:31pm, Monday, 14'th Sep 2020
Lilly said its drug, baricitinib, branded as Olumiant, in combination with remdesivir cut the median recovery time by about a day, compared to patients treated with remdesivir alone
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
11:48am, Monday, 14'th Sep 2020
Eli Lily & Co. undefined and Incyte Corp. undefined said Monday that their rheumatoid arthritis drug Olumiant helped reduce recovery time in hospitalized...
Lilly’s Rheumatoid Arthritis Drug Shortens Covid-19 Hospitalization When Combined With Antiviral Med
12:00am, Monday, 14'th Sep 2020
The pharmaceutical company said its drug baricitinib, combined with remdesivir, reduces median hospital stays by one day compared to remdesivir alone, and is pursuing an emergency use authorization wi
Albornoces de hombre y mujer para secarse tras un baño relajante
03:00am, Friday, 11'th Sep 2020
Vestir un albornoz es una gran idea después de salir de darte un baño en la piscina o la ducha. Descubre todas las ventajas que aporta esta suave prenda de origen árabe
Regeneron’s Virus Treatment Has Probably Missed the Bus
06:02pm, Thursday, 10'th Sep 2020
A successful and cheap vaccine will render the expensive antibody cocktails obsolete for preventing Covid, Benchmark analyst Aydin Huseynov says.
2 Coronavirus Treatment Stocks to Buy Right Now | The Motley Fool
02:00pm, Wednesday, 09'th Sep 2020
Eli Lilly and Kamada are two of the most intriguing companies working on this part of the COVID-19 problem.
Research Reports
12:04am, Saturday, 05'th Sep 2020
Analysts report on Eli Lilly, Rocket Cos., Tenet Healthcare, Intercontinental Exchange, and Copart
